Treatment Alternatives for Drug-naïve Schizophrenia in Japan

UMIN ID: UMIN000002228

Registered date:21/07/2009

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Schizophrenia
• Date of first enrollment: 2009/04/01
• Target sample size: 600
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): Treatment with aripiprazole for 8 weeks

Outcome(s)

• Primary Outcome: improvement of schizophrenia symptoms
• Secondary Outcome: adverse effects

Key inclusion & exclusion criteria

• Age minimum: 16years-old
• Age maximum: 65years-old
• Gender: Male and Female
• Exclude criteria: 1)Patinets with organic illness 2)Patinets with diabetis 3)Patinets with mental ritardation 4)Patinets who have mediation histrory with antipsychotics within 1 month 5)Patinets with severe suicidal thought

Related Information

• Primary Sponsor: Resarch enforcement group, Japanese Sciety of Clinical Neuropsychopharmacology
• Source(s) of Monetary Support: Japanese Sciety of Clinical Neuropsychopharmacology